◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 0286

Aidigong Maternal & Child Health Limited (0286) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Care Facilities · DATA UPDATED 2026-08-10

Aidigong Maternal & Child Health Limited (0286) operates in the Medical Care Facilities industry and is headquartered in Wan Chai, Hong Kong with about 1,338 employees. Its market capitalization is roughly HKD 254 million. In the fiscal year ended 2023-12-31, 0286 reported HKD 555M in revenue and (HKD 177M) in net income.

Aidigong Maternal & Child Health Limited, an investment holding company, provides postpartum care and healthcare services in the People's Republic of China. The company operates through Postpartum Care Services, Health Industry, and Other segments.

Interactive charts & full statements →

0286 Revenue & Earnings History — Annual Income Statement

Income statement2023-12-312022-12-312021-12-31
Total RevenueHKD 555MHKD 680MHKD 643M
Gross ProfitHKD 121MHKD 99MHKD 205M
Operating Income (EBIT)(HKD 134M)(HKD 163M)HKD 39M
Net Income(HKD 177M)(HKD 165M)HKD 5M

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0286 Free Cash Flow History

0286 Balance Sheet History

Balance sheet2023-12-312022-12-312021-12-31
Total AssetsHKD 2.0BHKD 2.2BHKD 3.0B
Total LiabilitiesHKD 1.2BHKD 1.3BHKD 1.8B

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0286 viewer.

Other Companies in Medical Care Facilities

← 0285All “0-9” companies0287 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.